Pathophysiology of Hepatic Encephalopathy.

Clin Liver Dis

Section of Digestive Diseases, Yale Liver Center, Yale University School of Medicine, 333 Cedar Street, LMP 1080, New Haven, CT 06520-8019, USA; VA Connecticut Healthcare System, West Haven, Connecticut, USA. Electronic address:

Published: May 2020

Hepatic encephalopathy (HE) is one of the major clinical decompensations of cirrhosis, with a high impact on health care resource utilization and cost. For an effective and comprehensive management of HE, the clinicians need to understand the pathophysiologic mechanisms of HE. This review describes the multiorgan processes involved in HE and how several HE precipitants and treatment strategies act on ammonia production, excretion, and neurotoxicity, including the impact of diabetes and use of cannabinoids. The authors also discuss the current and future role of gut microbiome, systemic/central inflammation, and various neurotransmitters for the pathogenesis and treatment of HE.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cld.2020.01.002DOI Listing

Publication Analysis

Top Keywords

hepatic encephalopathy
8
pathophysiology hepatic
4
encephalopathy hepatic
4
encephalopathy major
4
major clinical
4
clinical decompensations
4
decompensations cirrhosis
4
cirrhosis high
4
high impact
4
impact health
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!